E Fund Management Co., Ltd. Allakos Inc. Transaction History

E Fund Management Co., Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$3.6 - $5.25 $8,834 - $12,883	-2,454 Reduced 11.44%	18,996 $83,000
Q1 2023 May 11, 2023	BUY	$4.3 - $8.27 $20,214 - $38,877	4,701 Added 28.07%	21,450 $95,000
Q4 2022 Feb 14, 2023	BUY	$5.66 - $8.42 $94,799 - $141,026	16,749 New	16,749 $141,000
Q1 2021 May 12, 2021	BUY	$109.73 - $153.66 $122,678 - $171,791	1,118 New	1,118 $128,000

66.9M

47.1K

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $22.9M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

Get notified when there are updates to the investment portfolio of E Fund Management Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on E Fund Management Co., Ltd. with notifications on news.